Neurothera Labs Inc.
NTLX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 142.50K | 142.50K | 159.00K | 236.00K | 230.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 142.50K | 142.50K | 159.00K | 236.00K | 230.50K |
| Cost of Revenue | 36.00K | 36.00K | 54.00K | 70.00K | 50.50K |
| Gross Profit | 106.50K | 106.50K | 105.00K | 166.00K | 180.00K |
| SG&A Expenses | 731.50K | 731.50K | 777.00K | 260.00K | 265.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26M | 1.26M | 2.63M | 330.00K | 793.50K |
| Operating Income | -1.12M | -1.12M | -2.47M | -94.00K | -563.00K |
| Income Before Tax | -1.10M | -1.10M | -4.08M | -94.00K | -563.00K |
| Income Tax Expenses | -- | -- | 19.00K | -- | -- |
| Earnings from Continuing Operations | -1.10M | -1.10M | -4.10M | -94.00K | -563.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 33.50K | 33.50K | 240.00K | -- | 41.50K |
| Net Income | -1.06M | -1.06M | -3.86M | -94.00K | -521.50K |
| EBIT | -1.12M | -1.12M | -2.47M | -94.00K | -563.00K |
| EBITDA | -1.07M | -1.07M | -2.42M | -46.00K | -515.00K |
| EPS Basic | -0.16 | -0.16 | -0.64 | -0.12 | -0.12 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.37 | -- | -0.07 |
| EPS Diluted | -0.16 | -0.16 | -0.64 | -0.12 | -0.12 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.37 | -- | -0.07 |
| Average Basic Shares Outstanding | 6.70M | 6.70M | 6.06M | -- | 4.52M |
| Average Diluted Shares Outstanding | 6.70M | 6.70M | 6.06M | 4.52M | 4.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |